Grail (GRAL) Free Cash Flow (2023 - 2026)
Grail's (GRAL) quarterly Free Cash Flow came in at -$81.2 million in Q2 2026, down 5.23% on a YoY basis from -$85.6 million in Q2 2025, and up 7.23% quarter-over-quarter from -$87.5 million in Q1 2026.
Analysis
Grail (GRAL) Free Cash Flow (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Free Cash Flow for 4 consecutive years, with -$81.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Free Cash Flow fell 5.23% year-over-year to -$81.2 million; the trailing twelve-month figure through Jun 2026 stood at -$296.2 million (up 20.33% YoY), and the FY2025 full-year result was -$299.9 million, up 48.5% from the prior year.
- Free Cash Flow grew to -$81.2 million in Q2 2026 per GRAL's latest filing, from -$87.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$63.6 million in Q3 2025 and bottomed at -$209.8 million in Q1 2024.
- Historically, Free Cash Flow has averaged -$112.4 million across 4 years, with a median of -$94.5 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Free Cash Flow soared 55.46% in 2025, then retreated 5.23% in 2026.
- Over 4 years, Free Cash Flow stood at -$140.7 million in 2023, then soared by 33.34% to -$93.8 million in 2024, then jumped by 31.89% to -$63.9 million in 2025, then declined by 27.06% to -$81.2 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$81.2 million, -$87.5 million, and -$63.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -8.64 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 459.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 313.90 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -69.54 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -13.65 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 6.40 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 42.05 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 5.09 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -7.58 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -81.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -81.16 Mn |
| Mar 31, 2026 | -87.49 Mn |
| Dec 31, 2025 | -63.88 Mn |
| Sep 30, 2025 | -63.63 Mn |
| Jun 30, 2025 | -77.13 Mn |
| Mar 31, 2025 | -95.28 Mn |
| Dec 31, 2024 | -93.79 Mn |
| Sep 30, 2024 | -105.55 Mn |
| Jun 30, 2024 | -173.19 Mn |
| Mar 31, 2024 | -209.83 Mn |
| Dec 31, 2023 | -140.70 Mn |
| Oct 1, 2023 | -157.46 Mn |